| Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis Nature 476 (7359), 214-219, 2011 | 3066 | 2011 |
| B-cell depletion with rituximab in relapsing–remitting multiple sclerosis SL Hauser, E Waubant, DL Arnold, T Vollmer, J Antel, RJ Fox, A Bar-Or, ... New England Journal of Medicine 358 (7), 676-688, 2008 | 2822 | 2008 |
| Ocrelizumab versus placebo in primary progressive multiple sclerosis X Montalban, SL Hauser, L Kappos, DL Arnold, A Bar-Or, G Comi, ... New england journal of medicine 376 (3), 209-220, 2017 | 2031 | 2017 |
| Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis SL Hauser, A Bar-Or, G Comi, G Giovannoni, HP Hartung, B Hemmer, ... New England Journal of Medicine 376 (3), 221-234, 2017 | 1967 | 2017 |
| Sequential vs concurrent chemoradiation for stage III non–small cell lung cancer: randomized phase III trial RTOG 9410 WJ Curran Jr, R Paulus, CJ Langer, R Komaki, JS Lee, S Hauser, ... Journal of the National Cancer Institute 103 (19), 1452-1460, 2011 | 1442 | 2011 |
| Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis International IBD Genetics Consortium (IIBDGC), C Agliardi, L Alfredsson, ... Nature genetics 45 (11), 1353-1360, 2013 | 1371 | 2013 |
| Identification of autoantibodies associated with myelin damage in multiple sclerosis CP Genain, B Cannella, SL Hauser, CS Raine Nature medicine 5 (2), 170-175, 1999 | 1109 | 1999 |
| Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double‐blind placebo‐controlled multicenter trial K Hawker, P O'Connor, MS Freedman, PA Calabresi, J Antel, J Simon, ... Annals of neurology 66 (4), 460-471, 2009 | 1086 | 2009 |
| The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration SL Hauser, JR Oksenberg Neuron 52 (1), 61-76, 2006 | 1053 | 2006 |
| Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility International Multiple Sclerosis Genetics Consortium*†, ANZgene, ... Science 365 (6460), eaav7188, 2019 | 1024 | 2019 |
| Intensive immunosuppression in progressive multiple sclerosis: a randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH SL Hauser, DM Dawson, JR Lehrich, MF Beal, SV Kevy, RD Propper, ... New England Journal of Medicine 308 (4), 173-180, 1983 | 1024 | 1983 |
| Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci PL De Jager, X Jia, J Wang, PIW De Bakker, L Ottoboni, NT Aggarwal, ... Nature genetics 41 (7), 776-782, 2009 | 1017 | 2009 |
| Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models E Cekanaviciute, BB Yoo, TF Runia, JW Debelius, S Singh, CA Nelson, ... Proceedings of the National Academy of Sciences 114 (40), 10713-10718, 2017 | 976 | 2017 |
| Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial L Kappos, D Li, PA Calabresi, P O'Connor, A Bar-Or, F Barkhof, M Yin, ... The Lancet 378 (9805), 1779-1787, 2011 | 957 | 2011 |
| Treatment of multiple sclerosis: a review SL Hauser, BAC Cree The American journal of medicine 133 (12), 1380-1390. e2, 2020 | 852 | 2020 |
| Interleukin 7 receptor α chain ( IL7R ) shows allelic and functional association with multiple sclerosis SG Gregory, S Schmidt, P Seth, JR Oksenberg, J Hart, A Prokop, ... Nature genetics 39 (9), 1083-1091, 2007 | 843 | 2007 |
| A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex JL Haines, M Ter-Minassian, A Bazyk, JF Gusella, DJ Kim, H Terwedow, ... Nature genetics 13 (4), 469-471, 1996 | 826 | 1996 |
| Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome DT Okuda, EM Mowry, A Beheshtian, E Waubant, SE Baranzini, ... Neurology 72 (9), 800-805, 2009 | 772 | 2009 |
| T cell gelatinases mediate basement membrane transmigration in vitro. D Leppert, E Waubant, R Galardy, NW Bunnett, SL Hauser Journal of immunology (Baltimore, Md.: 1950) 154 (9), 4379-4389, 1995 | 639 | 1995 |
| Abnormal B‐cell cytokine responses a trigger of T‐cell–mediated disease in MS? A Bar‐Or, L Fawaz, B Fan, PJ Darlington, A Rieger, C Ghorayeb, ... Annals of neurology 67 (4), 452-461, 2010 | 617 | 2010 |
